BACLOFEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Baclofen, and when can generic versions of Baclofen launch?
Baclofen is a drug marketed by Acic Pharms, Amneal, Maia Pharms Inc, Mylan Labs Ltd, Rubicon, Ani Pharms, Appco, Aurobindo Pharma Ltd, Beximco Pharms Usa, Endo Operations, Eywa Pharma, Graviti Pharms, Impax, Innogenix, Ivax Sub Teva Pharms, Lannett Co Inc, Mankind Pharma, Micro Labs, Mylan, Northstar Hlthcare, Oxford Pharms, Rising, Sun Pharm Inds Inc, Teva, Unichem, Upsher Smith Labs, Usl Pharma, Watson Labs, and Zydus Lifesciences. and is included in forty-one NDAs.
The generic ingredient in BACLOFEN is baclofen. There are twenty-one drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the baclofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Baclofen
A generic version of BACLOFEN was approved as baclofen by IVAX SUB TEVA PHARMS on July 21st, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BACLOFEN?
- What are the global sales for BACLOFEN?
- What is Average Wholesale Price for BACLOFEN?
Summary for BACLOFEN
US Patents: | 0 |
Applicants: | 29 |
NDAs: | 41 |
Finished Product Suppliers / Packagers: | 54 |
Raw Ingredient (Bulk) Api Vendors: | 149 |
Clinical Trials: | 121 |
Patent Applications: | 4,705 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for BACLOFEN |
Drug Sales Revenues: | Drug sales revenues for BACLOFEN |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for BACLOFEN |
What excipients (inactive ingredients) are in BACLOFEN? | BACLOFEN excipients list |
DailyMed Link: | BACLOFEN at DailyMed |
![BACLOFEN drug patent expirations Drug patent expirations by year for BACLOFEN](/p/graph/s/t/BACLOFEN-patent-expirations.png)
![Drug Prices for BACLOFEN](/p/graph/drug-price/BACLOFEN.png)
![Drug Sales Revenue Trends for BACLOFEN](/p/graph/drug-sales-revenues/BACLOFEN.png)
Recent Clinical Trials for BACLOFEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kuwait University | Early Phase 1 |
Marmara University | N/A |
European University of Lefke | N/A |
Pharmacology for BACLOFEN
Drug Class | gamma-Aminobutyric Acid-ergic Agonist |
Mechanism of Action | GABA A Agonists GABA B Agonists |
Medical Subject Heading (MeSH) Categories for BACLOFEN
Anatomical Therapeutic Chemical (ATC) Classes for BACLOFEN
US Patents and Regulatory Information for BACLOFEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | BACLOFEN | baclofen | TABLET;ORAL | 072824-001 | Sep 18, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lannett Co Inc | BACLOFEN | baclofen | TABLET;ORAL | 077241-001 | Dec 20, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Impax | BACLOFEN | baclofen | TABLET;ORAL | 077971-001 | Oct 26, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan | BACLOFEN | baclofen | TABLET;ORAL | 077121-002 | Jul 29, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Rubicon | BACLOFEN | baclofen | TABLET;ORAL | 209102-003 | Nov 28, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Micro Labs | BACLOFEN | baclofen | TABLET;ORAL | 217687-001 | Nov 8, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |